We performed functional verification using 12-month-old APP/PS1 mice and found that PTAFR was highly expressed in the brain and peripheral blood of APP/PS1 mice, consistent with our prediction results, which suggested that PTAFR was a potential candidate biomarker for AD diagnosis. This evidence concerns the gene APP and Alzheimer disease.